CeriBell, Inc./$CBLL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CeriBell, Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Ticker

$CBLL
Sector
Primary listing

Employees

281

CeriBell, Inc. Metrics

BasicAdvanced
$463M
-
-$1.81
-
-

Bulls say / Bears say

Total revenue grew 42% year-over-year to $20.5 million in Q1 2025, driven by adoption by new accounts and expansion within the active account base
The FDA granted 510(k) clearance for Ceribell’s Clarity™ algorithm for patients aged 1 and older, making it the first AI-powered EEG system with pediatric seizure detection indication
Ceribell’s point-of-care EEG system received FedRAMP® High authorization—the highest federal cybersecurity designation—positioning it as the only medical device company with this approval for deployment across VA and other federal healthcare systems
Net loss widened to $12.8 million in Q1 2025 from $8.5 million a year earlier, reflecting ongoing unprofitability despite revenue growth
Operating expenses surged 55% to $32.2 million in Q1 2025, outpacing the 42% increase in revenue and putting pressure on profitability
The company remains exposed to supply chain risks and potential tariff impacts, as a substantial number of product components are manufactured and assembled in China, which could erode estimated gross margins
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CBLL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs